nodes	percent_of_prediction	percent_of_DWPC	metapath
Argatroban—CYP3A5—prostate cancer	0.267	0.698	CbGaD
Argatroban—CYP3A4—prostate cancer	0.115	0.302	CbGaD
Argatroban—CYP3A5—Flutamide—prostate cancer	0.0484	0.129	CbGbCtD
Argatroban—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0434	0.116	CbGbCtD
Argatroban—CYP3A5—Cabazitaxel—prostate cancer	0.0358	0.0957	CbGbCtD
Argatroban—CYP3A5—Estrone—prostate cancer	0.035	0.0935	CbGbCtD
Argatroban—CYP3A4—Bicalutamide—prostate cancer	0.0228	0.0609	CbGbCtD
Argatroban—CYP3A4—Estramustine—prostate cancer	0.0212	0.0566	CbGbCtD
Argatroban—CYP3A5—Estradiol—prostate cancer	0.0201	0.0537	CbGbCtD
Argatroban—CYP3A4—Flutamide—prostate cancer	0.0189	0.0504	CbGbCtD
Argatroban—CYP3A4—Abiraterone—prostate cancer	0.0189	0.0504	CbGbCtD
Argatroban—CYP3A4—Cabazitaxel—prostate cancer	0.014	0.0373	CbGbCtD
Argatroban—CYP3A4—Estrone—prostate cancer	0.0137	0.0365	CbGbCtD
Argatroban—CYP3A5—Etoposide—prostate cancer	0.0131	0.0351	CbGbCtD
Argatroban—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0122	0.0325	CbGbCtD
Argatroban—CYP3A5—Docetaxel—prostate cancer	0.012	0.0321	CbGbCtD
Argatroban—CYP3A4—Conjugated Estrogens—prostate cancer	0.00894	0.0239	CbGbCtD
Argatroban—CYP3A4—Mitoxantrone—prostate cancer	0.00812	0.0217	CbGbCtD
Argatroban—CYP3A4—Estradiol—prostate cancer	0.00784	0.0209	CbGbCtD
Argatroban—CYP3A4—Prednisone—prostate cancer	0.00675	0.018	CbGbCtD
Argatroban—F2—urine—prostate cancer	0.00656	0.374	CbGeAlD
Argatroban—CYP3A4—Etoposide—prostate cancer	0.00512	0.0137	CbGbCtD
Argatroban—CYP3A4—Docetaxel—prostate cancer	0.00469	0.0125	CbGbCtD
Argatroban—CYP3A4—Doxorubicin—prostate cancer	0.00349	0.00933	CbGbCtD
Argatroban—F2—prostate gland—prostate cancer	0.00236	0.134	CbGeAlD
Argatroban—CYP3A4—urine—prostate cancer	0.00199	0.114	CbGeAlD
Argatroban—F2—epithelium—prostate cancer	0.00173	0.0986	CbGeAlD
Argatroban—F2—renal system—prostate cancer	0.00161	0.0915	CbGeAlD
Argatroban—F2—bone marrow—prostate cancer	0.00121	0.0692	CbGeAlD
Argatroban—CYP3A5—prostate gland—prostate cancer	0.000953	0.0543	CbGeAlD
Argatroban—CYP3A5—renal system—prostate cancer	0.00065	0.037	CbGeAlD
Argatroban—CYP3A4—renal system—prostate cancer	0.000488	0.0278	CbGeAlD
Argatroban—Acute coronary syndrome—Docetaxel—prostate cancer	0.000116	0.000862	CcSEcCtD
Argatroban—Infection—Estradiol—prostate cancer	0.000116	0.00086	CcSEcCtD
Argatroban—Myocardial infarction—Docetaxel—prostate cancer	0.000115	0.000857	CcSEcCtD
Argatroban—Angiopathy—Etoposide—prostate cancer	0.000115	0.000857	CcSEcCtD
Argatroban—Abdominal pain—Conjugated Estrogens—prostate cancer	0.000115	0.000855	CcSEcCtD
Argatroban—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000115	0.000855	CcSEcCtD
Argatroban—Pneumonia—Capecitabine—prostate cancer	0.000114	0.000852	CcSEcCtD
Argatroban—Sepsis—Doxorubicin—prostate cancer	0.000114	0.000847	CcSEcCtD
Argatroban—Tachycardia—Estradiol—prostate cancer	0.000113	0.000845	CcSEcCtD
Argatroban—Vomiting—Ethinyl Estradiol—prostate cancer	0.000113	0.000844	CcSEcCtD
Argatroban—Chest pain—Mitoxantrone—prostate cancer	0.000113	0.000842	CcSEcCtD
Argatroban—Rash—Ethinyl Estradiol—prostate cancer	0.000112	0.000837	CcSEcCtD
Argatroban—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000112	0.000836	CcSEcCtD
Argatroban—Acute coronary syndrome—Capecitabine—prostate cancer	0.000112	0.000835	CcSEcCtD
Argatroban—Headache—Ethinyl Estradiol—prostate cancer	0.000112	0.000831	CcSEcCtD
Argatroban—Myocardial infarction—Capecitabine—prostate cancer	0.000111	0.00083	CcSEcCtD
Argatroban—Renal failure acute—Epirubicin—prostate cancer	0.000111	0.000829	CcSEcCtD
Argatroban—Urinary tract infection—Capecitabine—prostate cancer	0.000111	0.000823	CcSEcCtD
Argatroban—Thrombophlebitis—Doxorubicin—prostate cancer	0.00011	0.000818	CcSEcCtD
Argatroban—Confusional state—Mitoxantrone—prostate cancer	0.000109	0.000814	CcSEcCtD
Argatroban—Haematuria—Capecitabine—prostate cancer	0.000108	0.000807	CcSEcCtD
Argatroban—Hypersensitivity—Goserelin—prostate cancer	0.000108	0.000805	CcSEcCtD
Argatroban—Renal impairment—Epirubicin—prostate cancer	0.000108	0.000804	CcSEcCtD
Argatroban—Infection—Mitoxantrone—prostate cancer	0.000108	0.000802	CcSEcCtD
Argatroban—Dermatitis bullous—Epirubicin—prostate cancer	0.000108	0.000801	CcSEcCtD
Argatroban—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000107	0.000797	CcSEcCtD
Argatroban—Back pain—Etoposide—prostate cancer	0.000107	0.000795	CcSEcCtD
Argatroban—Haemoglobin—Docetaxel—prostate cancer	0.000106	0.000789	CcSEcCtD
Argatroban—Nausea—Ethinyl Estradiol—prostate cancer	0.000106	0.000788	CcSEcCtD
Argatroban—Tachycardia—Mitoxantrone—prostate cancer	0.000106	0.000787	CcSEcCtD
Argatroban—Haemorrhage—Docetaxel—prostate cancer	0.000105	0.000785	CcSEcCtD
Argatroban—Cardiac failure—Epirubicin—prostate cancer	0.000105	0.000784	CcSEcCtD
Argatroban—Cerebrovascular accident—Epirubicin—prostate cancer	0.000105	0.000781	CcSEcCtD
Argatroban—Bradycardia—Capecitabine—prostate cancer	0.000104	0.000774	CcSEcCtD
Argatroban—Dyspnoea—Estradiol—prostate cancer	0.000104	0.000772	CcSEcCtD
Argatroban—Renal failure acute—Doxorubicin—prostate cancer	0.000103	0.000767	CcSEcCtD
Argatroban—Gastrointestinal haemorrhage—Epirubicin—prostate cancer	0.000103	0.000765	CcSEcCtD
Argatroban—Haemoglobin—Capecitabine—prostate cancer	0.000103	0.000764	CcSEcCtD
Argatroban—Dyspepsia—Estradiol—prostate cancer	0.000102	0.000762	CcSEcCtD
Argatroban—Haemorrhage—Capecitabine—prostate cancer	0.000102	0.00076	CcSEcCtD
Argatroban—Hypotension—Mitoxantrone—prostate cancer	0.000101	0.000754	CcSEcCtD
Argatroban—Gastrointestinal disorder—Estradiol—prostate cancer	0.0001	0.000748	CcSEcCtD
Argatroban—Diarrhoea—Goserelin—prostate cancer	0.0001	0.000747	CcSEcCtD
Argatroban—Renal impairment—Doxorubicin—prostate cancer	9.99e-05	0.000744	CcSEcCtD
Argatroban—Acute coronary syndrome—Prednisone—prostate cancer	9.98e-05	0.000743	CcSEcCtD
Argatroban—Dermatitis bullous—Doxorubicin—prostate cancer	9.95e-05	0.000741	CcSEcCtD
Argatroban—Constipation—Estradiol—prostate cancer	9.94e-05	0.00074	CcSEcCtD
Argatroban—Pain—Estradiol—prostate cancer	9.94e-05	0.00074	CcSEcCtD
Argatroban—Diarrhoea—Conjugated Estrogens—prostate cancer	9.94e-05	0.00074	CcSEcCtD
Argatroban—Myocardial infarction—Prednisone—prostate cancer	9.93e-05	0.000739	CcSEcCtD
Argatroban—Cardiac arrest—Epirubicin—prostate cancer	9.77e-05	0.000728	CcSEcCtD
Argatroban—Cardiac failure—Doxorubicin—prostate cancer	9.74e-05	0.000726	CcSEcCtD
Argatroban—Cerebrovascular accident—Doxorubicin—prostate cancer	9.7e-05	0.000723	CcSEcCtD
Argatroban—Dizziness—Goserelin—prostate cancer	9.7e-05	0.000722	CcSEcCtD
Argatroban—Dyspnoea—Mitoxantrone—prostate cancer	9.66e-05	0.000719	CcSEcCtD
Argatroban—Cough—Etoposide—prostate cancer	9.64e-05	0.000718	CcSEcCtD
Argatroban—Dizziness—Conjugated Estrogens—prostate cancer	9.61e-05	0.000715	CcSEcCtD
Argatroban—Feeling abnormal—Estradiol—prostate cancer	9.58e-05	0.000714	CcSEcCtD
Argatroban—Angiopathy—Docetaxel—prostate cancer	9.56e-05	0.000712	CcSEcCtD
Argatroban—Dyspepsia—Mitoxantrone—prostate cancer	9.54e-05	0.00071	CcSEcCtD
Argatroban—Gastrointestinal haemorrhage—Doxorubicin—prostate cancer	9.51e-05	0.000708	CcSEcCtD
Argatroban—Gastrointestinal pain—Estradiol—prostate cancer	9.51e-05	0.000708	CcSEcCtD
Argatroban—Chest pain—Etoposide—prostate cancer	9.4e-05	0.0007	CcSEcCtD
Argatroban—Vomiting—Goserelin—prostate cancer	9.33e-05	0.000694	CcSEcCtD
Argatroban—Pain—Mitoxantrone—prostate cancer	9.27e-05	0.00069	CcSEcCtD
Argatroban—Constipation—Mitoxantrone—prostate cancer	9.27e-05	0.00069	CcSEcCtD
Argatroban—Angiopathy—Capecitabine—prostate cancer	9.26e-05	0.00069	CcSEcCtD
Argatroban—Bradycardia—Prednisone—prostate cancer	9.26e-05	0.000689	CcSEcCtD
Argatroban—Rash—Goserelin—prostate cancer	9.25e-05	0.000689	CcSEcCtD
Argatroban—Dermatitis—Goserelin—prostate cancer	9.24e-05	0.000688	CcSEcCtD
Argatroban—Vomiting—Conjugated Estrogens—prostate cancer	9.24e-05	0.000688	CcSEcCtD
Argatroban—Abdominal pain—Estradiol—prostate cancer	9.19e-05	0.000685	CcSEcCtD
Argatroban—Body temperature increased—Estradiol—prostate cancer	9.19e-05	0.000685	CcSEcCtD
Argatroban—Headache—Goserelin—prostate cancer	9.19e-05	0.000684	CcSEcCtD
Argatroban—Rash—Conjugated Estrogens—prostate cancer	9.16e-05	0.000682	CcSEcCtD
Argatroban—Dermatitis—Conjugated Estrogens—prostate cancer	9.15e-05	0.000682	CcSEcCtD
Argatroban—Haemoglobin—Prednisone—prostate cancer	9.14e-05	0.00068	CcSEcCtD
Argatroban—Headache—Conjugated Estrogens—prostate cancer	9.1e-05	0.000678	CcSEcCtD
Argatroban—Haemorrhage—Prednisone—prostate cancer	9.09e-05	0.000677	CcSEcCtD
Argatroban—Confusional state—Etoposide—prostate cancer	9.09e-05	0.000677	CcSEcCtD
Argatroban—Cardiac arrest—Doxorubicin—prostate cancer	9.04e-05	0.000673	CcSEcCtD
Argatroban—Infection—Etoposide—prostate cancer	8.95e-05	0.000667	CcSEcCtD
Argatroban—Feeling abnormal—Mitoxantrone—prostate cancer	8.93e-05	0.000665	CcSEcCtD
Argatroban—Back pain—Docetaxel—prostate cancer	8.88e-05	0.000661	CcSEcCtD
Argatroban—Gastrointestinal pain—Mitoxantrone—prostate cancer	8.86e-05	0.00066	CcSEcCtD
Argatroban—Tachycardia—Etoposide—prostate cancer	8.8e-05	0.000655	CcSEcCtD
Argatroban—Nausea—Goserelin—prostate cancer	8.71e-05	0.000649	CcSEcCtD
Argatroban—Angina pectoris—Epirubicin—prostate cancer	8.65e-05	0.000644	CcSEcCtD
Argatroban—Nausea—Conjugated Estrogens—prostate cancer	8.63e-05	0.000643	CcSEcCtD
Argatroban—Back pain—Capecitabine—prostate cancer	8.59e-05	0.00064	CcSEcCtD
Argatroban—Hypersensitivity—Estradiol—prostate cancer	8.57e-05	0.000638	CcSEcCtD
Argatroban—Abdominal pain—Mitoxantrone—prostate cancer	8.56e-05	0.000638	CcSEcCtD
Argatroban—Body temperature increased—Mitoxantrone—prostate cancer	8.56e-05	0.000638	CcSEcCtD
Argatroban—Hypotension—Etoposide—prostate cancer	8.42e-05	0.000627	CcSEcCtD
Argatroban—Angiopathy—Prednisone—prostate cancer	8.25e-05	0.000614	CcSEcCtD
Argatroban—Dyspnoea—Etoposide—prostate cancer	8.03e-05	0.000598	CcSEcCtD
Argatroban—Cough—Docetaxel—prostate cancer	8.01e-05	0.000596	CcSEcCtD
Argatroban—Angina pectoris—Doxorubicin—prostate cancer	8.01e-05	0.000596	CcSEcCtD
Argatroban—Hypersensitivity—Mitoxantrone—prostate cancer	7.98e-05	0.000594	CcSEcCtD
Argatroban—Pneumonia—Epirubicin—prostate cancer	7.97e-05	0.000593	CcSEcCtD
Argatroban—Diarrhoea—Estradiol—prostate cancer	7.96e-05	0.000592	CcSEcCtD
Argatroban—Chest pain—Docetaxel—prostate cancer	7.81e-05	0.000582	CcSEcCtD
Argatroban—Gastrointestinal disorder—Etoposide—prostate cancer	7.78e-05	0.000579	CcSEcCtD
Argatroban—Cough—Capecitabine—prostate cancer	7.75e-05	0.000577	CcSEcCtD
Argatroban—Constipation—Etoposide—prostate cancer	7.71e-05	0.000574	CcSEcCtD
Argatroban—Pain—Etoposide—prostate cancer	7.71e-05	0.000574	CcSEcCtD
Argatroban—Urinary tract infection—Epirubicin—prostate cancer	7.7e-05	0.000573	CcSEcCtD
Argatroban—Dizziness—Estradiol—prostate cancer	7.69e-05	0.000573	CcSEcCtD
Argatroban—Chest pain—Capecitabine—prostate cancer	7.56e-05	0.000563	CcSEcCtD
Argatroban—Haematuria—Epirubicin—prostate cancer	7.55e-05	0.000562	CcSEcCtD
Argatroban—Confusional state—Docetaxel—prostate cancer	7.55e-05	0.000562	CcSEcCtD
Argatroban—Infection—Docetaxel—prostate cancer	7.44e-05	0.000554	CcSEcCtD
Argatroban—Feeling abnormal—Etoposide—prostate cancer	7.43e-05	0.000553	CcSEcCtD
Argatroban—Diarrhoea—Mitoxantrone—prostate cancer	7.41e-05	0.000552	CcSEcCtD
Argatroban—Vomiting—Estradiol—prostate cancer	7.39e-05	0.000551	CcSEcCtD
Argatroban—Pneumonia—Doxorubicin—prostate cancer	7.37e-05	0.000549	CcSEcCtD
Argatroban—Gastrointestinal pain—Etoposide—prostate cancer	7.37e-05	0.000549	CcSEcCtD
Argatroban—Rash—Estradiol—prostate cancer	7.33e-05	0.000546	CcSEcCtD
Argatroban—Dermatitis—Estradiol—prostate cancer	7.32e-05	0.000545	CcSEcCtD
Argatroban—Confusional state—Capecitabine—prostate cancer	7.31e-05	0.000544	CcSEcCtD
Argatroban—Tachycardia—Docetaxel—prostate cancer	7.31e-05	0.000544	CcSEcCtD
Argatroban—Headache—Estradiol—prostate cancer	7.28e-05	0.000542	CcSEcCtD
Argatroban—Bradycardia—Epirubicin—prostate cancer	7.24e-05	0.000539	CcSEcCtD
Argatroban—Infection—Capecitabine—prostate cancer	7.2e-05	0.000536	CcSEcCtD
Argatroban—Haemoglobin—Epirubicin—prostate cancer	7.15e-05	0.000532	CcSEcCtD
Argatroban—Abdominal pain—Etoposide—prostate cancer	7.12e-05	0.000531	CcSEcCtD
Argatroban—Body temperature increased—Etoposide—prostate cancer	7.12e-05	0.000531	CcSEcCtD
Argatroban—Urinary tract infection—Doxorubicin—prostate cancer	7.12e-05	0.000531	CcSEcCtD
Argatroban—Haemorrhage—Epirubicin—prostate cancer	7.11e-05	0.00053	CcSEcCtD
Argatroban—Tachycardia—Capecitabine—prostate cancer	7.08e-05	0.000527	CcSEcCtD
Argatroban—Hypotension—Docetaxel—prostate cancer	7e-05	0.000521	CcSEcCtD
Argatroban—Haematuria—Doxorubicin—prostate cancer	6.99e-05	0.00052	CcSEcCtD
Argatroban—Nausea—Estradiol—prostate cancer	6.91e-05	0.000514	CcSEcCtD
Argatroban—Vomiting—Mitoxantrone—prostate cancer	6.89e-05	0.000513	CcSEcCtD
Argatroban—Rash—Mitoxantrone—prostate cancer	6.83e-05	0.000509	CcSEcCtD
Argatroban—Dermatitis—Mitoxantrone—prostate cancer	6.82e-05	0.000508	CcSEcCtD
Argatroban—Headache—Mitoxantrone—prostate cancer	6.79e-05	0.000505	CcSEcCtD
Argatroban—Hypotension—Capecitabine—prostate cancer	6.78e-05	0.000505	CcSEcCtD
Argatroban—Bradycardia—Doxorubicin—prostate cancer	6.7e-05	0.000499	CcSEcCtD
Argatroban—Dyspnoea—Docetaxel—prostate cancer	6.68e-05	0.000497	CcSEcCtD
Argatroban—Hypersensitivity—Etoposide—prostate cancer	6.64e-05	0.000494	CcSEcCtD
Argatroban—Haemoglobin—Doxorubicin—prostate cancer	6.61e-05	0.000492	CcSEcCtD
Argatroban—Dyspepsia—Docetaxel—prostate cancer	6.59e-05	0.000491	CcSEcCtD
Argatroban—Haemorrhage—Doxorubicin—prostate cancer	6.58e-05	0.00049	CcSEcCtD
Argatroban—Gastrointestinal disorder—Docetaxel—prostate cancer	6.47e-05	0.000482	CcSEcCtD
Argatroban—Dyspnoea—Capecitabine—prostate cancer	6.46e-05	0.000481	CcSEcCtD
Argatroban—Angiopathy—Epirubicin—prostate cancer	6.45e-05	0.00048	CcSEcCtD
Argatroban—Nausea—Mitoxantrone—prostate cancer	6.44e-05	0.000479	CcSEcCtD
Argatroban—Infection—Prednisone—prostate cancer	6.42e-05	0.000478	CcSEcCtD
Argatroban—Pain—Docetaxel—prostate cancer	6.4e-05	0.000477	CcSEcCtD
Argatroban—Constipation—Docetaxel—prostate cancer	6.4e-05	0.000477	CcSEcCtD
Argatroban—Dyspepsia—Capecitabine—prostate cancer	6.38e-05	0.000475	CcSEcCtD
Argatroban—Tachycardia—Prednisone—prostate cancer	6.3e-05	0.000469	CcSEcCtD
Argatroban—Gastrointestinal disorder—Capecitabine—prostate cancer	6.26e-05	0.000466	CcSEcCtD
Argatroban—Constipation—Capecitabine—prostate cancer	6.2e-05	0.000462	CcSEcCtD
Argatroban—Pain—Capecitabine—prostate cancer	6.2e-05	0.000462	CcSEcCtD
Argatroban—Feeling abnormal—Docetaxel—prostate cancer	6.17e-05	0.00046	CcSEcCtD
Argatroban—Diarrhoea—Etoposide—prostate cancer	6.17e-05	0.000459	CcSEcCtD
Argatroban—Gastrointestinal pain—Docetaxel—prostate cancer	6.12e-05	0.000456	CcSEcCtD
Argatroban—Back pain—Epirubicin—prostate cancer	5.99e-05	0.000446	CcSEcCtD
Argatroban—Feeling abnormal—Capecitabine—prostate cancer	5.98e-05	0.000445	CcSEcCtD
Argatroban—Angiopathy—Doxorubicin—prostate cancer	5.97e-05	0.000445	CcSEcCtD
Argatroban—Dizziness—Etoposide—prostate cancer	5.96e-05	0.000444	CcSEcCtD
Argatroban—Gastrointestinal pain—Capecitabine—prostate cancer	5.93e-05	0.000442	CcSEcCtD
Argatroban—Abdominal pain—Docetaxel—prostate cancer	5.92e-05	0.000441	CcSEcCtD
Argatroban—Body temperature increased—Docetaxel—prostate cancer	5.92e-05	0.000441	CcSEcCtD
Argatroban—Body temperature increased—Capecitabine—prostate cancer	5.73e-05	0.000427	CcSEcCtD
Argatroban—Abdominal pain—Capecitabine—prostate cancer	5.73e-05	0.000427	CcSEcCtD
Argatroban—Vomiting—Etoposide—prostate cancer	5.73e-05	0.000427	CcSEcCtD
Argatroban—Dyspepsia—Prednisone—prostate cancer	5.69e-05	0.000423	CcSEcCtD
Argatroban—Rash—Etoposide—prostate cancer	5.68e-05	0.000423	CcSEcCtD
Argatroban—Dermatitis—Etoposide—prostate cancer	5.68e-05	0.000423	CcSEcCtD
Argatroban—Headache—Etoposide—prostate cancer	5.65e-05	0.00042	CcSEcCtD
Argatroban—Back pain—Doxorubicin—prostate cancer	5.54e-05	0.000413	CcSEcCtD
Argatroban—Constipation—Prednisone—prostate cancer	5.52e-05	0.000411	CcSEcCtD
Argatroban—Hypersensitivity—Docetaxel—prostate cancer	5.52e-05	0.000411	CcSEcCtD
Argatroban—Cough—Epirubicin—prostate cancer	5.4e-05	0.000402	CcSEcCtD
Argatroban—Nausea—Etoposide—prostate cancer	5.35e-05	0.000399	CcSEcCtD
Argatroban—Hypersensitivity—Capecitabine—prostate cancer	5.34e-05	0.000398	CcSEcCtD
Argatroban—Feeling abnormal—Prednisone—prostate cancer	5.32e-05	0.000396	CcSEcCtD
Argatroban—Gastrointestinal pain—Prednisone—prostate cancer	5.28e-05	0.000393	CcSEcCtD
Argatroban—Chest pain—Epirubicin—prostate cancer	5.27e-05	0.000392	CcSEcCtD
Argatroban—Diarrhoea—Docetaxel—prostate cancer	5.12e-05	0.000382	CcSEcCtD
Argatroban—Abdominal pain—Prednisone—prostate cancer	5.11e-05	0.00038	CcSEcCtD
Argatroban—Body temperature increased—Prednisone—prostate cancer	5.11e-05	0.00038	CcSEcCtD
Argatroban—Confusional state—Epirubicin—prostate cancer	5.09e-05	0.000379	CcSEcCtD
Argatroban—Infection—Epirubicin—prostate cancer	5.02e-05	0.000374	CcSEcCtD
Argatroban—Cough—Doxorubicin—prostate cancer	5e-05	0.000372	CcSEcCtD
Argatroban—Diarrhoea—Capecitabine—prostate cancer	4.96e-05	0.000369	CcSEcCtD
Argatroban—Dizziness—Docetaxel—prostate cancer	4.95e-05	0.000369	CcSEcCtD
Argatroban—Tachycardia—Epirubicin—prostate cancer	4.93e-05	0.000367	CcSEcCtD
Argatroban—Chest pain—Doxorubicin—prostate cancer	4.88e-05	0.000363	CcSEcCtD
Argatroban—Dizziness—Capecitabine—prostate cancer	4.8e-05	0.000357	CcSEcCtD
Argatroban—Vomiting—Docetaxel—prostate cancer	4.76e-05	0.000355	CcSEcCtD
Argatroban—Hypersensitivity—Prednisone—prostate cancer	4.76e-05	0.000354	CcSEcCtD
Argatroban—Rash—Docetaxel—prostate cancer	4.72e-05	0.000352	CcSEcCtD
Argatroban—Hypotension—Epirubicin—prostate cancer	4.72e-05	0.000352	CcSEcCtD
Argatroban—Dermatitis—Docetaxel—prostate cancer	4.72e-05	0.000351	CcSEcCtD
Argatroban—Confusional state—Doxorubicin—prostate cancer	4.71e-05	0.000351	CcSEcCtD
Argatroban—Headache—Docetaxel—prostate cancer	4.69e-05	0.000349	CcSEcCtD
Argatroban—Infection—Doxorubicin—prostate cancer	4.64e-05	0.000346	CcSEcCtD
Argatroban—Vomiting—Capecitabine—prostate cancer	4.61e-05	0.000343	CcSEcCtD
Argatroban—Rash—Capecitabine—prostate cancer	4.57e-05	0.00034	CcSEcCtD
Argatroban—Dermatitis—Capecitabine—prostate cancer	4.57e-05	0.00034	CcSEcCtD
Argatroban—Tachycardia—Doxorubicin—prostate cancer	4.56e-05	0.00034	CcSEcCtD
Argatroban—Headache—Capecitabine—prostate cancer	4.54e-05	0.000338	CcSEcCtD
Argatroban—Dyspnoea—Epirubicin—prostate cancer	4.5e-05	0.000335	CcSEcCtD
Argatroban—Nausea—Docetaxel—prostate cancer	4.45e-05	0.000331	CcSEcCtD
Argatroban—Dyspepsia—Epirubicin—prostate cancer	4.45e-05	0.000331	CcSEcCtD
Argatroban—Diarrhoea—Prednisone—prostate cancer	4.42e-05	0.000329	CcSEcCtD
Argatroban—Hypotension—Doxorubicin—prostate cancer	4.37e-05	0.000325	CcSEcCtD
Argatroban—Gastrointestinal disorder—Epirubicin—prostate cancer	4.36e-05	0.000325	CcSEcCtD
Argatroban—Constipation—Epirubicin—prostate cancer	4.32e-05	0.000322	CcSEcCtD
Argatroban—Pain—Epirubicin—prostate cancer	4.32e-05	0.000322	CcSEcCtD
Argatroban—Nausea—Capecitabine—prostate cancer	4.31e-05	0.000321	CcSEcCtD
Argatroban—Dizziness—Prednisone—prostate cancer	4.27e-05	0.000318	CcSEcCtD
Argatroban—Dyspnoea—Doxorubicin—prostate cancer	4.17e-05	0.00031	CcSEcCtD
Argatroban—Feeling abnormal—Epirubicin—prostate cancer	4.16e-05	0.00031	CcSEcCtD
Argatroban—Gastrointestinal pain—Epirubicin—prostate cancer	4.13e-05	0.000308	CcSEcCtD
Argatroban—Dyspepsia—Doxorubicin—prostate cancer	4.11e-05	0.000306	CcSEcCtD
Argatroban—Vomiting—Prednisone—prostate cancer	4.11e-05	0.000306	CcSEcCtD
Argatroban—Rash—Prednisone—prostate cancer	4.07e-05	0.000303	CcSEcCtD
Argatroban—Dermatitis—Prednisone—prostate cancer	4.07e-05	0.000303	CcSEcCtD
Argatroban—Headache—Prednisone—prostate cancer	4.05e-05	0.000301	CcSEcCtD
Argatroban—Gastrointestinal disorder—Doxorubicin—prostate cancer	4.04e-05	0.000301	CcSEcCtD
Argatroban—Pain—Doxorubicin—prostate cancer	4e-05	0.000298	CcSEcCtD
Argatroban—Constipation—Doxorubicin—prostate cancer	4e-05	0.000298	CcSEcCtD
Argatroban—Abdominal pain—Epirubicin—prostate cancer	3.99e-05	0.000297	CcSEcCtD
Argatroban—Body temperature increased—Epirubicin—prostate cancer	3.99e-05	0.000297	CcSEcCtD
Argatroban—Feeling abnormal—Doxorubicin—prostate cancer	3.85e-05	0.000287	CcSEcCtD
Argatroban—Nausea—Prednisone—prostate cancer	3.84e-05	0.000286	CcSEcCtD
Argatroban—Gastrointestinal pain—Doxorubicin—prostate cancer	3.82e-05	0.000285	CcSEcCtD
Argatroban—Hypersensitivity—Epirubicin—prostate cancer	3.72e-05	0.000277	CcSEcCtD
Argatroban—Body temperature increased—Doxorubicin—prostate cancer	3.7e-05	0.000275	CcSEcCtD
Argatroban—Abdominal pain—Doxorubicin—prostate cancer	3.7e-05	0.000275	CcSEcCtD
Argatroban—Diarrhoea—Epirubicin—prostate cancer	3.46e-05	0.000257	CcSEcCtD
Argatroban—Hypersensitivity—Doxorubicin—prostate cancer	3.44e-05	0.000256	CcSEcCtD
Argatroban—Dizziness—Epirubicin—prostate cancer	3.34e-05	0.000249	CcSEcCtD
Argatroban—Vomiting—Epirubicin—prostate cancer	3.21e-05	0.000239	CcSEcCtD
Argatroban—Diarrhoea—Doxorubicin—prostate cancer	3.2e-05	0.000238	CcSEcCtD
Argatroban—Rash—Epirubicin—prostate cancer	3.19e-05	0.000237	CcSEcCtD
Argatroban—Dermatitis—Epirubicin—prostate cancer	3.18e-05	0.000237	CcSEcCtD
Argatroban—Headache—Epirubicin—prostate cancer	3.16e-05	0.000236	CcSEcCtD
Argatroban—Dizziness—Doxorubicin—prostate cancer	3.09e-05	0.00023	CcSEcCtD
Argatroban—Nausea—Epirubicin—prostate cancer	3e-05	0.000223	CcSEcCtD
Argatroban—Vomiting—Doxorubicin—prostate cancer	2.97e-05	0.000221	CcSEcCtD
Argatroban—Rash—Doxorubicin—prostate cancer	2.95e-05	0.000219	CcSEcCtD
Argatroban—Dermatitis—Doxorubicin—prostate cancer	2.94e-05	0.000219	CcSEcCtD
Argatroban—Headache—Doxorubicin—prostate cancer	2.93e-05	0.000218	CcSEcCtD
Argatroban—Nausea—Doxorubicin—prostate cancer	2.78e-05	0.000207	CcSEcCtD
Argatroban—CYP3A5—Metabolism—TCN2—prostate cancer	1.32e-05	0.000144	CbGpPWpGaD
Argatroban—F2—Hemostasis—VEGFA—prostate cancer	1.32e-05	0.000144	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—CXCL8—prostate cancer	1.28e-05	0.000139	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CG—prostate cancer	1.26e-05	0.000138	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SLC22A3—prostate cancer	1.26e-05	0.000138	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—HSD3B1—prostate cancer	1.26e-05	0.000138	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CASP9—prostate cancer	1.25e-05	0.000137	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3CD—prostate cancer	1.22e-05	0.000134	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PRKCQ—prostate cancer	1.21e-05	0.000132	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NGFR—prostate cancer	1.21e-05	0.000132	CbGpPWpGaD
Argatroban—F2—Hemostasis—TGFB1—prostate cancer	1.21e-05	0.000132	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—TBXAS1—prostate cancer	1.21e-05	0.000132	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTA4—prostate cancer	1.21e-05	0.000132	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MAP3K7—prostate cancer	1.2e-05	0.000131	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—CTNNB1—prostate cancer	1.18e-05	0.000129	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTA2—prostate cancer	1.18e-05	0.000129	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SULT1A1—prostate cancer	1.16e-05	0.000127	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ABCG5—prostate cancer	1.16e-05	0.000127	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—FGF10—prostate cancer	1.15e-05	0.000126	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ADI1—prostate cancer	1.15e-05	0.000126	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PSAT1—prostate cancer	1.15e-05	0.000126	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CSAD—prostate cancer	1.15e-05	0.000126	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—TST—prostate cancer	1.15e-05	0.000126	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GRHL1—prostate cancer	1.15e-05	0.000126	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CBR1—prostate cancer	1.15e-05	0.000126	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ADRB2—prostate cancer	1.14e-05	0.000124	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTA1—prostate cancer	1.13e-05	0.000124	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—JAK2—prostate cancer	1.12e-05	0.000123	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTO1—prostate cancer	1.12e-05	0.000123	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—HSD3B2—prostate cancer	1.12e-05	0.000123	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—NAT2—prostate cancer	1.12e-05	0.000123	CbGpPWpGaD
Argatroban—F2—Hemostasis—KRAS—prostate cancer	1.12e-05	0.000122	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—MAP2K1—prostate cancer	1.12e-05	0.000122	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CD—prostate cancer	1.11e-05	0.000121	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—VAV3—prostate cancer	1.11e-05	0.000121	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TGFBR2—prostate cancer	1.09e-05	0.00012	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ITPR1—prostate cancer	1.08e-05	0.000118	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—LRP2—prostate cancer	1.08e-05	0.000118	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PLCB2—prostate cancer	1.08e-05	0.000118	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP2C18—prostate cancer	1.08e-05	0.000118	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CKMT2—prostate cancer	1.07e-05	0.000117	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GRHPR—prostate cancer	1.07e-05	0.000117	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—UGT2B15—prostate cancer	1.07e-05	0.000117	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—UGT2B17—prostate cancer	1.07e-05	0.000117	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3CB—prostate cancer	1.07e-05	0.000117	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—P4HB—prostate cancer	1.05e-05	0.000115	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IGF1R—prostate cancer	1.03e-05	0.000113	CbGpPWpGaD
Argatroban—F2—Hemostasis—PIK3CA—prostate cancer	1.03e-05	0.000112	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SLC22A1—prostate cancer	1.03e-05	0.000112	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CXCL8—prostate cancer	1.03e-05	0.000112	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—JAK2—prostate cancer	1.02e-05	0.000111	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—RFK—prostate cancer	1e-05	0.00011	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTM3—prostate cancer	1e-05	0.00011	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PGAM2—prostate cancer	1e-05	0.00011	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—AOX1—prostate cancer	1e-05	0.00011	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SULT2B1—prostate cancer	1e-05	0.00011	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—NAGLU—prostate cancer	1e-05	0.00011	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—MBTPS1—prostate cancer	1e-05	0.00011	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SULT2A1—prostate cancer	1e-05	0.000109	CbGpPWpGaD
Argatroban—F2—Hemostasis—TP53—prostate cancer	9.95e-06	0.000109	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—LPL—prostate cancer	9.87e-06	0.000108	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—MED12—prostate cancer	9.84e-06	0.000108	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—IL2—prostate cancer	9.8e-06	0.000107	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PDGFRB—prostate cancer	9.78e-06	0.000107	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GNG5—prostate cancer	9.76e-06	0.000107	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CB—prostate cancer	9.69e-06	0.000106	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ITGB3—prostate cancer	9.53e-06	0.000104	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP3A43—prostate cancer	9.52e-06	0.000104	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—AMACR—prostate cancer	9.52e-06	0.000104	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SRD5A2—prostate cancer	9.52e-06	0.000104	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—DEGS1—prostate cancer	9.52e-06	0.000104	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—NAT1—prostate cancer	9.52e-06	0.000104	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—NCOA3—prostate cancer	9.4e-06	0.000103	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CXCL8—prostate cancer	9.31e-06	0.000102	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ERBB3—prostate cancer	9.25e-06	0.000101	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—FGFR2—prostate cancer	9.23e-06	0.000101	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HSD17B1—prostate cancer	9.08e-06	9.93e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—HPGDS—prostate cancer	8.97e-06	9.81e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP2C19—prostate cancer	8.91e-06	9.74e-05	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL2—prostate cancer	8.9e-06	9.72e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TERT—prostate cancer	8.86e-06	9.69e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ACHE—prostate cancer	8.7e-06	9.51e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTT1—prostate cancer	8.7e-06	9.51e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP2A6—prostate cancer	8.6e-06	9.4e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HIF1A—prostate cancer	8.48e-06	9.27e-05	CbGpPWpGaD
Argatroban—F2—Hemostasis—AKT1—prostate cancer	8.41e-06	9.19e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—AKR1C3—prostate cancer	8.37e-06	9.14e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PRKACB—prostate cancer	8.32e-06	9.1e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—LEP—prostate cancer	8.27e-06	9.05e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP17A1—prostate cancer	8.24e-06	9e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CAV1—prostate cancer	8.2e-06	8.96e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—KDR—prostate cancer	8.11e-06	8.86e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—B4GALT4—prostate cancer	8.09e-06	8.85e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HPGD—prostate cancer	8.09e-06	8.85e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ESR1—prostate cancer	7.9e-06	8.64e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—NCOA2—prostate cancer	7.85e-06	8.58e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—BAD—prostate cancer	7.71e-06	8.43e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—TNFRSF21—prostate cancer	7.61e-06	8.32e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SLC5A5—prostate cancer	7.49e-06	8.18e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—APC—prostate cancer	7.47e-06	8.16e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CG—prostate cancer	7.47e-06	8.16e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP7B1—prostate cancer	7.4e-06	8.09e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—MTAP—prostate cancer	7.4e-06	8.09e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—EGF—prostate cancer	7.38e-06	8.07e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IRS1—prostate cancer	7.38e-06	8.07e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP2E1—prostate cancer	7.31e-06	7.99e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—NQO1—prostate cancer	7.23e-06	7.9e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SULT1E1—prostate cancer	7.21e-06	7.89e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SRD5A1—prostate cancer	7.21e-06	7.89e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GSK3B—prostate cancer	7.17e-06	7.83e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—TH—prostate cancer	7.13e-06	7.79e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—INS—prostate cancer	7.07e-06	7.73e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP3A4—prostate cancer	7.05e-06	7.71e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP1B1—prostate cancer	6.93e-06	7.58e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CREBBP—prostate cancer	6.92e-06	7.57e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ACSL4—prostate cancer	6.88e-06	7.52e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HSD17B3—prostate cancer	6.88e-06	7.52e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IGF1—prostate cancer	6.84e-06	7.47e-05	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—EGFR—prostate cancer	6.8e-06	7.44e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GGT1—prostate cancer	6.71e-06	7.34e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—NCOA1—prostate cancer	6.61e-06	7.23e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MAP2K1—prostate cancer	6.61e-06	7.22e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PHGDH—prostate cancer	6.6e-06	7.21e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—UMPS—prostate cancer	6.6e-06	7.21e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ARG2—prostate cancer	6.6e-06	7.21e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CD—prostate cancer	6.56e-06	7.18e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP19A1—prostate cancer	6.52e-06	7.12e-05	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3CA—prostate cancer	6.5e-06	7.11e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SERPINE1—prostate cancer	6.49e-06	7.1e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—LDHB—prostate cancer	6.47e-06	7.07e-05	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—KRAS—prostate cancer	6.43e-06	7.03e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP3A5—prostate cancer	6.35e-06	6.94e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—RXRA—prostate cancer	6.29e-06	6.88e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—FGF2—prostate cancer	6.29e-06	6.87e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NOS3—prostate cancer	6.2e-06	6.78e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PDHA1—prostate cancer	6.13e-06	6.71e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—UCP3—prostate cancer	6.13e-06	6.71e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—TCN2—prostate cancer	6.13e-06	6.71e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTA3—prostate cancer	6.13e-06	6.71e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—COMT—prostate cancer	6.06e-06	6.62e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTP1—prostate cancer	6.03e-06	6.59e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—JAK2—prostate cancer	6.03e-06	6.59e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ITPR1—prostate cancer	5.93e-06	6.49e-05	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CA—prostate cancer	5.91e-06	6.45e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MDM2—prostate cancer	5.88e-06	6.43e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HSD3B1—prostate cancer	5.85e-06	6.4e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SLC22A3—prostate cancer	5.85e-06	6.4e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ERBB2—prostate cancer	5.8e-06	6.34e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CB—prostate cancer	5.72e-06	6.26e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—TBXAS1—prostate cancer	5.61e-06	6.13e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTA4—prostate cancer	5.61e-06	6.13e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—TYMS—prostate cancer	5.61e-06	6.13e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTM1—prostate cancer	5.54e-06	6.06e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CXCL8—prostate cancer	5.5e-06	6.01e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTA2—prostate cancer	5.47e-06	5.98e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—LPL—prostate cancer	5.44e-06	5.95e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SULT1A1—prostate cancer	5.4e-06	5.9e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ABCG5—prostate cancer	5.4e-06	5.9e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CDKN1B—prostate cancer	5.37e-06	5.87e-05	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—AKT1—prostate cancer	5.31e-06	5.81e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTA1—prostate cancer	5.28e-06	5.77e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CASP3—prostate cancer	5.26e-06	5.75e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL2—prostate cancer	5.26e-06	5.74e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP1A1—prostate cancer	5.25e-06	5.74e-05	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL6—prostate cancer	5.23e-06	5.72e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HSD3B2—prostate cancer	5.22e-06	5.7e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—NAT2—prostate cancer	5.22e-06	5.7e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTO1—prostate cancer	5.22e-06	5.7e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ERCC2—prostate cancer	5.21e-06	5.7e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCND1—prostate cancer	5.12e-06	5.6e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CTNNB1—prostate cancer	5.07e-06	5.55e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PLCB2—prostate cancer	5e-06	5.47e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP2C18—prostate cancer	5e-06	5.47e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—LRP2—prostate cancer	5e-06	5.47e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MMP9—prostate cancer	4.97e-06	5.44e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CDKN1A—prostate cancer	4.96e-06	5.42e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PTEN—prostate cancer	4.94e-06	5.41e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—P4HB—prostate cancer	4.9e-06	5.36e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—MTHFR—prostate cancer	4.9e-06	5.35e-05	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—AKT1—prostate cancer	4.82e-06	5.27e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PPARA—prostate cancer	4.8e-06	5.25e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SLC22A1—prostate cancer	4.77e-06	5.22e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—EP300—prostate cancer	4.72e-06	5.15e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SULT2A1—prostate cancer	4.65e-06	5.08e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SRC—prostate cancer	4.59e-06	5.01e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—MED12—prostate cancer	4.57e-06	5e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GNG5—prostate cancer	4.54e-06	4.96e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CAV1—prostate cancer	4.52e-06	4.94e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—VEGFA—prostate cancer	4.47e-06	4.88e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—STAT3—prostate cancer	4.42e-06	4.83e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—NCOA3—prostate cancer	4.37e-06	4.78e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HPGDS—prostate cancer	4.17e-06	4.56e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP2C19—prostate cancer	4.14e-06	4.53e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CG—prostate cancer	4.11e-06	4.5e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MYC—prostate cancer	4.11e-06	4.49e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TGFB1—prostate cancer	4.1e-06	4.48e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ACHE—prostate cancer	4.04e-06	4.42e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTT1—prostate cancer	4.04e-06	4.42e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—EGFR—prostate cancer	4.02e-06	4.39e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP2A6—prostate cancer	4e-06	4.37e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—INS—prostate cancer	3.9e-06	4.26e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—AKR1C3—prostate cancer	3.89e-06	4.25e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PRKACB—prostate cancer	3.87e-06	4.23e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP17A1—prostate cancer	3.83e-06	4.19e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CREBBP—prostate cancer	3.82e-06	4.17e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—KRAS—prostate cancer	3.8e-06	4.15e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—NCOA2—prostate cancer	3.65e-06	3.99e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CD—prostate cancer	3.62e-06	3.95e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CA—prostate cancer	3.49e-06	3.81e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SLC5A5—prostate cancer	3.48e-06	3.8e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—NOS3—prostate cancer	3.42e-06	3.73e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP2E1—prostate cancer	3.4e-06	3.72e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TP53—prostate cancer	3.37e-06	3.69e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—NQO1—prostate cancer	3.36e-06	3.67e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—TH—prostate cancer	3.31e-06	3.62e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP1B1—prostate cancer	3.22e-06	3.52e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CB—prostate cancer	3.15e-06	3.45e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PTGS2—prostate cancer	3.12e-06	3.42e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GGT1—prostate cancer	3.12e-06	3.41e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL6—prostate cancer	3.09e-06	3.38e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—NCOA1—prostate cancer	3.07e-06	3.36e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP19A1—prostate cancer	3.03e-06	3.31e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—RXRA—prostate cancer	2.92e-06	3.2e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—AKT1—prostate cancer	2.85e-06	3.12e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—COMT—prostate cancer	2.82e-06	3.08e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTP1—prostate cancer	2.8e-06	3.06e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ITPR1—prostate cancer	2.76e-06	3.02e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PTEN—prostate cancer	2.72e-06	2.98e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—TYMS—prostate cancer	2.61e-06	2.85e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—EP300—prostate cancer	2.6e-06	2.84e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTM1—prostate cancer	2.58e-06	2.82e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—LPL—prostate cancer	2.53e-06	2.76e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.44e-06	2.67e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ERCC2—prostate cancer	2.42e-06	2.65e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—MTHFR—prostate cancer	2.28e-06	2.49e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PPARA—prostate cancer	2.23e-06	2.44e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CAV1—prostate cancer	2.1e-06	2.3e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CA—prostate cancer	1.92e-06	2.1e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.91e-06	2.09e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—INS—prostate cancer	1.81e-06	1.98e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CREBBP—prostate cancer	1.77e-06	1.94e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.68e-06	1.84e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—NOS3—prostate cancer	1.59e-06	1.74e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—AKT1—prostate cancer	1.57e-06	1.72e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.47e-06	1.6e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PTGS2—prostate cancer	1.45e-06	1.59e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PTEN—prostate cancer	1.27e-06	1.38e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—EP300—prostate cancer	1.21e-06	1.32e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CA—prostate cancer	8.94e-07	9.77e-06	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—AKT1—prostate cancer	7.3e-07	7.98e-06	CbGpPWpGaD
